Authors


Farris K. Timimi, MD

Latest:

Mayo Clinic Expert on Social Media: An Opportunity for Psychiatrists

As the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient.


Farzin Irani, MS

Latest:

Predicting Outcome in Schizophrenia

Can sociodemographic and clinical variables predict outcome in cases of schizophrenia? Results from studies related to prognostic variables for schizophrenia have yielded interesting yet inconsistent results.


Fatima Noorani, MD

Latest:

7 Medical Illnesses That May Present as Anxiety

Beyond psychosocial implications of anxiety disorders, an array of physiological effects may ensue.


Felicia Kleinberg, MSW

Latest:

The Link Between Substance Abuse, Violence, and Suicide

Emerging research suggests that some individuals with particular types of substance use and abuse may be more likely to engage in suicidal behaviors. For example, those who use opiates, cocaine, or sedatives may have a noticeably higher risk of suicide than those who use other drugs.


Fidel Vila-Rodriguez, MD

Latest:

Repetitive Transcranial Magnetic Stimulation in Depression: A Changing Landscape

Clinicians can feel confident in the evidence base when referring patients with a moderate level of treatment resistance for rTMS. Preliminary results suggest that deep rTMS may be an effective option in patients who have failed to respond to more than one antidepressant treatment.


Filippo Bogetto, MD

Latest:

Mood Stabilizers and Novel Antipsychotics in the Treatment of Borderline Personality Disorder

This article focuses on data concerning the efficacy of mood stabilizers in the treatment of BPD.


Flavie Waters, MSc, MPsych, PhD

Latest:

Auditory Hallucinations in Adult Populations

This article focuses on auditory hallucinations, which occur in a range of psychiatric and medical disorders as well as in individuals without mental illness.


Flavie Waters, PhD

Latest:

Auditory Hallucinations in Psychiatric Illness

An overview of the characteristics of auditory hallucinations in people with psychiatric illness, and a brief review of treatment options.


Florence C. Dalcanto, MD

Latest:

Cerebral Palsy: A Multisystem Review

Cerebral Palsy: A Multisystem Review


Fragiskos Gonidakis, MD

Latest:

Little-known Facts About Eating Disorders in Older Patients

Eating disorders can frequently be unrecognized or masked behind medical conditions, depression, or the natural changes of aging.


Frances Levin, MD

Latest:

Treatment for Cannabis Use Disorders: A Case Report

It is vital that psychiatrists are able to identify and characterize cannabis use disorders; provide education; and offer effective, evidence-based treatments. This article provides a brief overview of each of these topics.


Francesca Cannavo Antognini, PhD

Latest:

Psychotherapy and Combined Therapy for Depressive Disorders in Later Life

Geriatric psychotherapy has begun to receive consistent and supportive attention in the psychiatric literature. Despite this growing interest in psychotherapy for older adults, studies of efficacy of either psychotherapy alone or of combined treatments for older patients are still limited in number, and more attention to the issue is needed.


Francine Goodman, PharmD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


Francis Lotrich, MD, PhD

Latest:

Clinical Manual of Geriatric Psychopharmacology

To assist in meeting the daunting challenge of medication management, the Clinical Manual of Geriatric Psychopharmacology is a valuable, up-to-date resource for any clinician who prescribes for elderly patients.


Francis M. Mondimore, MD

Latest:

Never-Ending Winter: Chronic Depression

Mood disorders are among the most prevalent forms of mental illness. Serious depression is especially common; based on a face-to-face survey conducted from December 2001 to December 2002, the past-year prevalence rate of clinically significant major depressive disorder (MDD) was estimated to be 6.6%, affecting at least 13.1 to 14.2 million Americans.


Francis Mondimore, MD

Latest:

Borderline Personality Disorder: New Reasons for Hope

Borderline Personality Disorder: New Reasons for Hope is one in a series being published by Johns Hopkins University Press on major psychiatric disorders.


Francisca Azocar, PhD

Latest:

Intervention Helps Workers With Depression

In the US, depression ranks fifth in the number of disability-adjusted life years lost due to illness and employment problems often persist, even if help is sought. Helping those who want and/or need to work is part of providing comprehensive, patient-centered care.


Francisco A. Moreno, MD

Latest:

Treatment-Resistant Depression: The Role of Gene Factors

Major depressive disorder (MDD) affects a large proportion of the world's population, but much still needs to be done to categorically improve the lives of people with this condition.


Franco Benazzi, MD, PhD

Latest:

Bipolar II Disorder: Current Issues in Diagnosis and Management

Three issues of current concern in bipolar II disorder include: diagnostic criteria for hypomania, diagnosis of mixed depression, and management of mixed depression.


Frank Ayd Jr, MD

Latest:

International Psychopharmacology Research

A longitudinal study of the nicotine patch for smoking abstinence and a look at new drugs to lower blood pressure in patients with cerebrovascular disease are among the various research studies from Europe, Australia and Asia highlighted in this column.


Frank Vocci, PhD

Latest:

Bringing New Medications to the Treatment of Addiction

Substance abuse and addiction are among the most challenging health problems facing our society. Breakthrough discoveries in science continue to refine our understanding of drug abuse and addiction and are yielding new opportunities to translate basic research findings into tangible treatment products. Read about the progress being made by the National Institute on Drug Abuse, the world's largest supporter of research on the health aspects of addiction.


Franklin R. Schneier, MD

Latest:

Tools for Assessing Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is a chronic, impairing and highly comorbid psychiatric condition. A small but sufficient group of empirically supported instruments to assess the severity of GAD are now available.


Franz Resch, MD

Latest:

Headache in Children and Psychiatric Problems

Headache is a frequent somatic complaint in childhood and adolescence, and its prevalence has increased over the last few decades. The presence of a comorbid psychiatric disorder tends to worsen the course of headache by increasing attack frequency and severity, making the headaches less responsive to treatment, and increasing the risk of chronification. Identification and treatment of comorbid psychiatric conditions is, therefore, important for the proper management of headache, especially in children and adolescents.


Fred D. Sheftell, MD

Latest:

Headache and Psychiatric Comorbidity

Migraine affects approximately 12% of the population, and a high percentage of these patients have comorbid psychiatric disorders. Knowing more about the interaction between headache and psychiatric factors can assist in evaluating and treating these patients.


Fred Ovsiew, MD

Latest:

Introduction: Neuropsychiatry Is Thriving

Neuropsychiatry is thriving, and the articles in this Special Report demonstrate its breadth and depth while providing the opportunity to characterize and delimit its scope.


Fred S. Berlin, MD, PhD

Latest:

Mini Quiz: Obligation to Report Abuse

When did the US Supreme Court confirm the authority of states to intervene in family relationships to protect children? Find out in this quiz.


Fred Volkmar, MD

Latest:

Current Clinical Practice in Asperger Disorder

Hans Asperger considered the disorder a personality factor rather than a developmental issue. How things have changed.


Fred W. Sabb, PhD

Latest:

From Bench to Bedside: The Future of Neuroimaging Tools in Diagnosis and Treatment

Schizophrenia poses a challenge for diagnosis and treatment at least in part because it remains a syndromal diagnosis without clearly understood neuropathological bases or treatments with clearly understood mechanisms of action. Neuroimaging research promises to advance understanding of the unique pathological processes that contribute to this syndrome, and to foster both better appreciation of how current treatments work, and how future treatments should be developed.


Frederick M. Ehrlich, MD

Latest:

Psychoanalysis and Couple Therapy

Meeting the mental health needs of the millions of immigrants from diverse cultural backgrounds and homelands who now live in the United States may require more than a thorough knowledge of psychiatry or psychology, according to a number of cultural psychiatric practitioners.


Frederick S. Mendelsohn, MD

Latest:

Choosing Appropriate Techniques

The use of supportive psychotherapy, where the clinician acts as a watchful parent, may be of some use to certain patients as opposed to traditional psychoanalysis. This paper gives some examples of cases in which supportive psychotherapy may be more effective.

© 2024 MJH Life Sciences

All rights reserved.